Pain Management Devices Market - By Product Type (Neurostimulation Devices, Analgesic Infusion Pumps, Ablation Devices), By Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain), By End-use (Hospitals and Clinics) & Forecast, 2024 – 2032

Pain Management Devices Market Size

Pain Management Devices Market size valued at USD 4.4 billion in 2023 and is poised to grow at over 8.9% CAGR from 2024 to 2032. Favorable reimbursement policies, technological advancements, growing aging population and increasing prevalence of chronic pain are among the key attributes driving the demand for pain management devices.
 

Pain management devices are medical devices that are specifically designed to help alleviate or control pain. These devices are intended to be used as part of a comprehensive pain management plan and can provide relief for various types of pain, including chronic pain, acute pain, and postoperative pain. Pain management devices work through various mechanisms, such as electrical stimulation, thermal therapy, or drug delivery.

Pain management devices, especially those involving implantation or invasive procedures, undergo rigorous regulatory scrutiny to ensure safety and efficacy. The pain management devices may not be equally accessible in all regions due to variations in healthcare infrastructure, resource constraints, and healthcare disparities. Lack of availability and limited distribution channels in certain regions can hinder market growth and limit patient access to these devices. Further, pain management devices can be expensive, particularly advanced neurostimulation implants and drug delivery systems. The high cost of these devices can limit their accessibility, especially in regions with limited healthcare budgets or inadequate insurance coverage.
 

COVID-19 Impact

The recent outbreak of COVID-19 had negatively influenced the pain management devices market revenue in 2020. The global pandemic disrupted supply chains and manufacturing operations, leading to delays in the production and distribution of pain management devices. During the pandemic, many healthcare systems were burdened with COVID-19 cases, leading to a prioritization of resources and a significant reduction in elective procedures. Non-essential surgeries and interventions, including pain management procedures involving devices, were often postponed, or cancelled that resulted in decreased demand for pain management devices. However, as the situation evolved and healthcare systems adapted to the pandemic, the market recovered in the following years, especially as deferred procedures resumed, and healthcare services normalize.
 

Pain Management Devices Market Trends

Chronic pain is often a long-term condition requiring ongoing management. Home-based pain management devices ensure continuity of care by providing consistent access to treatments and therapies without any disruptions. Homecare settings provide individuals with the convenience and comfort of managing their chronic pain in their own familiar environment. Home-based pain management devices offer potential cost savings compared to repeated visits to healthcare facilities and individuals can avoid expenses related to transportation, and other parameters. Furthermore, long-term use of pain management devices at home can be more cost-effective than ongoing clinic or hospital visits.
 

Pain Management Devices Market Analysis

Based on product type, the pain management devices market is bifurcated into neurostimulation devices, analgesic infusion pumps, and ablation devices. The neurostimulation devices segment surpassed USD 3 billion in 2022. Neurostimulation devices allow for targeted pain relief by directly stimulating nerves or neural pathways involved in transmitting pain signals. By modulating the neural activity, these devices can interrupt or modify pain signals before they reach the brain, providing localized pain relief in specific areas of the body. Additionally, factors such as non-pharmacological pain management, personalized therapy, and technological advancements are expected to further fuel the segmental progression.
 

Based on application, the pain management devices market is segmented into neuropathic pain, facial & migraine pain, cancer pain, musculoskeletal pain, and others. The neuropathic pain segment exceeds USD 2.8 billion by 2032. Neuropathic pain is a common and challenging condition characterized by abnormal pain processing in the nervous system. The high prevalence of neuropathic pain creates a significant demand for effective pain management options, including the use of pain management devices. Moreover, there is a growing body of clinical evidence supporting the effectiveness of pain management devices in neuropathic pain management.
 

Based on end-use, the pain management devices market is categorized into hospitals, physiotherapy centers, and others. The hospitals and clinics segment held a majority share in 2022 and is set to cross USD 4.5 billion by 2032. Hospitals and clinics have well-established safety protocols and monitoring systems to ensure patient safety during pain management device procedures. These facilities typically have access to advanced medical technologies and equipment required for pain management device procedures. They may have specialized operating rooms, imaging facilities, and other infrastructure necessary for implanting or using neurostimulation devices and other advanced pain management interventions.
 

Further availability of specialized pain management departments or centers with experienced healthcare professionals, collaboration with multiple specialties and reimbursement facilities are other attributes that are predicted to boost the segmental revenue.
 

North America pain management devices market is anticipated to reach around USD 4 billion by 2032. North America has a well-developed and advanced healthcare infrastructure with state-of-the-art hospitals, clinics, and research institutions. The region has a strong network of healthcare facilities that specialize in pain management and have the necessary infrastructure and expertise to adopt and utilize pain management devices effectively. Similarly, favorable reimbursement policies, strong research and evidence base through clinical trials, and technological advancements and innovation is expected to further fuel the regional industry growth.
 

Pain Management Devices Market Share

Some of the leading companies operating in the pain management devices market include:

• Boston Scientific Corporation
• Medtronic plc
• B. Braun Melsungen AG
• Stryker Corporation
• Abbott Laboratories
• Stim Wave Technologies,
• Nevro Corporation
   

The pain management devices industry is competitive in nature, with major players, and local regional companies, along with new start-ups focusing on improved product offerings that is further consolidating the industry competition. The key participants are involved in strategic developments including partnerships & collaboration, product launches, mergers, and acquisition to improve their industry positioning.
 

Pain Management Devices Industry News:

• In August 2022, Abbott announced that it has received the FDA approval for its Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy. Company's BurstDR stimulation, FlexBurst360 therapy offers pain coverage across up to six areas of the trunk or limbs. Moreover, it enables programming that can be adjusted as a person's therapeutic needs evolve over time. Such strategic development will enable the company to improve its product offering and increase business prospects.
   
• In January 2020, Medtronic acquired Stimgenics, a privately held American company to boost its pain therapies business. This development will aid company in integrating Stimgenics novel spinal cord stimulation (SCS) waveform that is used to treat patient with chronic pain. This strategic acquisition helped the company to enhance their business prospects in the industry.
   

This pain management devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in (USD Million) and volume (Units) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product Type

• Neurostimulation Devices
  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Others
• Analgesic Infusion Pumps
• Ablation Devices

By Application

• Neuropathic Pain
• Musculoskeletal Pain
• Cancer Pain
• Facial & Migraine Pain
• Others

By End-use

• Hospitals and Clinics
• Physiotherapy Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Peru
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Israel
  • Iran